Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiji Fang

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Biomaterials Science|July 3, 2023
Recombinant supercharged polypeptides for safe and efficient heparin neutralizationJianfei Tu, Qing Liu, Shengye You, et al.
Journal of Nanobiotechnology|December 28, 2025
Plain DNA and cationic aromatics: a platform to simplify carrier-free delivery systemsShiji Fang, Zhongwei Zhao, Huaping Li, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 22, 2020
Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinomaQiaoyou Weng, Minjiang Chen, Weibin Yang, et al.
Lipids in Health and Disease|October 1, 2024
Glycerophospholipid-driven lipid metabolic reprogramming as a common key mechanism in the progression of human primary hepatocellular carcinoma and cholangiocarcinomaYanran Bi, Xihui Ying, Wanbin Chen, et al.
Cellular Signalling|December 5, 2024
Corrigendum to "Fangchinoline inhibits metastasis and reduces inflammation-induced epithelial-mesenchymal transition by targeting the FOXM1-ADAM17 axis in hepatocellular carcinoma" [Cell Signal. 2024 Dec:124:111467]Liyun Zheng, Vinothkumar Rajamanickam, Mengyuan Wang, et al.
Cellular Signalling|October 11, 2024
Fangchinoline inhibits metastasis and reduces inflammation-induced epithelial-mesenchymal transition by targeting the FOXM1-ADAM17 axis in hepatocellular carcinomaLiyun Zheng, Vinothkumar Rajamanickam, Mengyuan Wang, et al.
European Journal of Radiology|October 2, 2021
Construction of a novel radiomics nomogram for the prediction of aggressive intrasegmental recurrence of HCC after radiofrequency ablationXiuling Lv, Minjiang Chen, Chunli Kong, et al.
Cell Death & Disease|April 20, 2022
xCT contributes to colorectal cancer tumorigenesis through upregulation of the MELK oncogene and activation of the AKT/mTOR cascadeBufu Tang, Jinyu Zhu, Fangming Liu, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 30, 2020
Fucoidan-based micelles as P-selectin targeted carriers for synergistic treatment of acute kidney injuryGaofeng Shu, Chenying Lu, Zhixian Wang, et al.
Journal of Inflammation Research|September 1, 2021
Predictive Models for HCC Prognosis, Recurrence Risk, and Immune Infiltration Based on Two Exosomal Genes: <i>MYL6B</i> and <i>THOC2</i>Jinyu Zhu, Bufu Tang, Yang Gao, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Biomaterials Science|July 3, 2023
Recombinant supercharged polypeptides for safe and efficient heparin neutralizationJianfei Tu, Qing Liu, Shengye You, et al.
Journal of Nanobiotechnology|December 28, 2025
Plain DNA and cationic aromatics: a platform to simplify carrier-free delivery systemsShiji Fang, Zhongwei Zhao, Huaping Li, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 22, 2020
Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinomaQiaoyou Weng, Minjiang Chen, Weibin Yang, et al.
Lipids in Health and Disease|October 1, 2024
Glycerophospholipid-driven lipid metabolic reprogramming as a common key mechanism in the progression of human primary hepatocellular carcinoma and cholangiocarcinomaYanran Bi, Xihui Ying, Wanbin Chen, et al.
Cellular Signalling|December 5, 2024
Corrigendum to "Fangchinoline inhibits metastasis and reduces inflammation-induced epithelial-mesenchymal transition by targeting the FOXM1-ADAM17 axis in hepatocellular carcinoma" [Cell Signal. 2024 Dec:124:111467]Liyun Zheng, Vinothkumar Rajamanickam, Mengyuan Wang, et al.
Cellular Signalling|October 11, 2024
Fangchinoline inhibits metastasis and reduces inflammation-induced epithelial-mesenchymal transition by targeting the FOXM1-ADAM17 axis in hepatocellular carcinomaLiyun Zheng, Vinothkumar Rajamanickam, Mengyuan Wang, et al.
European Journal of Radiology|October 2, 2021
Construction of a novel radiomics nomogram for the prediction of aggressive intrasegmental recurrence of HCC after radiofrequency ablationXiuling Lv, Minjiang Chen, Chunli Kong, et al.
Cell Death & Disease|April 20, 2022
xCT contributes to colorectal cancer tumorigenesis through upregulation of the MELK oncogene and activation of the AKT/mTOR cascadeBufu Tang, Jinyu Zhu, Fangming Liu, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 30, 2020
Fucoidan-based micelles as P-selectin targeted carriers for synergistic treatment of acute kidney injuryGaofeng Shu, Chenying Lu, Zhixian Wang, et al.
Journal of Inflammation Research|September 1, 2021
Predictive Models for HCC Prognosis, Recurrence Risk, and Immune Infiltration Based on Two Exosomal Genes: <i>MYL6B</i> and <i>THOC2</i>Jinyu Zhu, Bufu Tang, Yang Gao, et al.
Pageof 8